Suppression of apoptosis in perfusion culture of Myeloma NS0 cells enhances cell growth but reduces antibody productivity
A spin filter perfusion systems was used to achieve a high cell density culture for two NS0 cell lines in 2 litres bioreactors. One cell line is transfected with the bcl-2 gene (NS0 Bcl-2) encodes the 'anti-apoptotic' human Bcl-2 protein and the other cell line (NS0 Control) with a blank v...
Gespeichert in:
Veröffentlicht in: | Apoptosis (London) 2004-11, Vol.9 (6), p.843-852 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 852 |
---|---|
container_issue | 6 |
container_start_page | 843 |
container_title | Apoptosis (London) |
container_volume | 9 |
creator | Tey, B T Al-Rubeai, M |
description | A spin filter perfusion systems was used to achieve a high cell density culture for two NS0 cell lines in 2 litres bioreactors. One cell line is transfected with the bcl-2 gene (NS0 Bcl-2) encodes the 'anti-apoptotic' human Bcl-2 protein and the other cell line (NS0 Control) with a blank vector. The runs started as batch cultures for two days and were perfused with fresh medium at 0.5 volumes per day (day(-1)) for 4 days, increasing gradually to 2 day(-1) at day 7. The increase of the viable cell density of Bcl-2 cell line was far greater than the control cell line, although they were perfused with the same amount of medium. At the end of the period of each perfusion rate, the viable cell densities of Bcl-2 culture were 30%, 120%, 160% and 220% higher than its control cell line corresponding values. Overall, there was a roughly 9 fold increase in viable cell density from the inoculum for the control culture, but almost a 30 fold increase for the Bcl-2 culture. The mode of cell death in the control culture was initially predominantly by necrosis (viability higher than 80%), but apoptotic cell death became more significant after day 8 of the culture. Cell death in the Bcl-2 culture was almost entirely by necrosis, although it remained at a very low level (less than 5%) to the termination time. The cell cycle distributions for both cell lines were very much similar indicating they have a similar doubling time and G1 to S progression rate. Interestingly, the Bcl-2 cultures exhibited reduced antibody specific production rate with increasing viable cell number and time. The volumetric production rate was, however, similar in both cultures. Bcl-2 as an anti-death protein allowed cells to survive and thus divide to higher cell densities without the need for additional nutrients. Most of the cellular energy in a producer cell line is used for biomass production rather than for antibody production, as was the case with the control cell line. |
doi_str_mv | 10.1023/b:appt.0000045792.63249.5a |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67005209</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2156636791</sourcerecordid><originalsourceid>FETCH-LOGICAL-c441t-f926561b65119c805fbb57c145a850ea3adabbee9d8103c51615b9e40d5aff763</originalsourceid><addsrcrecordid>eNqFkctO3TAQhi1UBJTyCpXForuc-pJxYnYUFVqJmwSV2Fl24pSgnNj1pShvT3I4EhIbZuO5fDPj0Y_QMSUrShj_bk6092lFFiuhkmwlOCvlCvQOOqBQ8UJU8PBp9rkgRU1r2EefY3yacV7zcg_tUwACJRMHaLrL3gcbY-9G7DqsvfPJxT7ifsTehi5vKk0eUg52Ia4mO7i1xtd3BDd2GCK246MeGxs3If4b3HN6xCYnHGybl7weU29cO2Ef3JxJ_f8-TV_QbqeHaI-27yH6c_7z_uxXcXlz8fvs9LJoypKmopNMgKBGAKWyqQl0xkDV0BJ0DcRqrlttjLWyrSnhDVBBwUhbkhZ011WCH6Jvr3Pn5f-yjUmt-7j8VI_W5ahERQgwIj8EqawYFaSeweN34JPLYZyPUBUISaRkbIZOXqEmuBiD7ZQP_VqHSVGiFhnVD3V6e3uv3mRUGxkV6Ln563ZDNmvbvrVudeMvobucRg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>756909922</pqid></control><display><type>article</type><title>Suppression of apoptosis in perfusion culture of Myeloma NS0 cells enhances cell growth but reduces antibody productivity</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Tey, B T ; Al-Rubeai, M</creator><creatorcontrib>Tey, B T ; Al-Rubeai, M</creatorcontrib><description>A spin filter perfusion systems was used to achieve a high cell density culture for two NS0 cell lines in 2 litres bioreactors. One cell line is transfected with the bcl-2 gene (NS0 Bcl-2) encodes the 'anti-apoptotic' human Bcl-2 protein and the other cell line (NS0 Control) with a blank vector. The runs started as batch cultures for two days and were perfused with fresh medium at 0.5 volumes per day (day(-1)) for 4 days, increasing gradually to 2 day(-1) at day 7. The increase of the viable cell density of Bcl-2 cell line was far greater than the control cell line, although they were perfused with the same amount of medium. At the end of the period of each perfusion rate, the viable cell densities of Bcl-2 culture were 30%, 120%, 160% and 220% higher than its control cell line corresponding values. Overall, there was a roughly 9 fold increase in viable cell density from the inoculum for the control culture, but almost a 30 fold increase for the Bcl-2 culture. The mode of cell death in the control culture was initially predominantly by necrosis (viability higher than 80%), but apoptotic cell death became more significant after day 8 of the culture. Cell death in the Bcl-2 culture was almost entirely by necrosis, although it remained at a very low level (less than 5%) to the termination time. The cell cycle distributions for both cell lines were very much similar indicating they have a similar doubling time and G1 to S progression rate. Interestingly, the Bcl-2 cultures exhibited reduced antibody specific production rate with increasing viable cell number and time. The volumetric production rate was, however, similar in both cultures. Bcl-2 as an anti-death protein allowed cells to survive and thus divide to higher cell densities without the need for additional nutrients. Most of the cellular energy in a producer cell line is used for biomass production rather than for antibody production, as was the case with the control cell line.</description><identifier>ISSN: 1360-8185</identifier><identifier>EISSN: 1573-675X</identifier><identifier>DOI: 10.1023/b:appt.0000045792.63249.5a</identifier><identifier>PMID: 15505426</identifier><language>eng</language><publisher>Netherlands: Springer Nature B.V</publisher><subject>Antibodies, Monoclonal - biosynthesis ; Apoptosis ; Bacteria ; Bioreactors ; Cell Count ; Cell Culture Techniques ; Cell cycle ; Cell Proliferation ; Cell Survival ; Culture Media - analysis ; Enzyme-Linked Immunosorbent Assay ; Glucose - analysis ; Humans ; Hybridomas - cytology ; Immunoglobulin G - analysis ; Microscopy, Confocal ; Mortality ; Multiple Myeloma - immunology ; Multiple Myeloma - pathology ; Proteins ; Proto-Oncogene Proteins c-bcl-2 - analysis ; Proto-Oncogene Proteins c-bcl-2 - genetics ; Time Factors ; Transfection</subject><ispartof>Apoptosis (London), 2004-11, Vol.9 (6), p.843-852</ispartof><rights>Kluwer Academic Publishers 2004</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c441t-f926561b65119c805fbb57c145a850ea3adabbee9d8103c51615b9e40d5aff763</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15505426$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tey, B T</creatorcontrib><creatorcontrib>Al-Rubeai, M</creatorcontrib><title>Suppression of apoptosis in perfusion culture of Myeloma NS0 cells enhances cell growth but reduces antibody productivity</title><title>Apoptosis (London)</title><addtitle>Apoptosis</addtitle><description>A spin filter perfusion systems was used to achieve a high cell density culture for two NS0 cell lines in 2 litres bioreactors. One cell line is transfected with the bcl-2 gene (NS0 Bcl-2) encodes the 'anti-apoptotic' human Bcl-2 protein and the other cell line (NS0 Control) with a blank vector. The runs started as batch cultures for two days and were perfused with fresh medium at 0.5 volumes per day (day(-1)) for 4 days, increasing gradually to 2 day(-1) at day 7. The increase of the viable cell density of Bcl-2 cell line was far greater than the control cell line, although they were perfused with the same amount of medium. At the end of the period of each perfusion rate, the viable cell densities of Bcl-2 culture were 30%, 120%, 160% and 220% higher than its control cell line corresponding values. Overall, there was a roughly 9 fold increase in viable cell density from the inoculum for the control culture, but almost a 30 fold increase for the Bcl-2 culture. The mode of cell death in the control culture was initially predominantly by necrosis (viability higher than 80%), but apoptotic cell death became more significant after day 8 of the culture. Cell death in the Bcl-2 culture was almost entirely by necrosis, although it remained at a very low level (less than 5%) to the termination time. The cell cycle distributions for both cell lines were very much similar indicating they have a similar doubling time and G1 to S progression rate. Interestingly, the Bcl-2 cultures exhibited reduced antibody specific production rate with increasing viable cell number and time. The volumetric production rate was, however, similar in both cultures. Bcl-2 as an anti-death protein allowed cells to survive and thus divide to higher cell densities without the need for additional nutrients. Most of the cellular energy in a producer cell line is used for biomass production rather than for antibody production, as was the case with the control cell line.</description><subject>Antibodies, Monoclonal - biosynthesis</subject><subject>Apoptosis</subject><subject>Bacteria</subject><subject>Bioreactors</subject><subject>Cell Count</subject><subject>Cell Culture Techniques</subject><subject>Cell cycle</subject><subject>Cell Proliferation</subject><subject>Cell Survival</subject><subject>Culture Media - analysis</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>Glucose - analysis</subject><subject>Humans</subject><subject>Hybridomas - cytology</subject><subject>Immunoglobulin G - analysis</subject><subject>Microscopy, Confocal</subject><subject>Mortality</subject><subject>Multiple Myeloma - immunology</subject><subject>Multiple Myeloma - pathology</subject><subject>Proteins</subject><subject>Proto-Oncogene Proteins c-bcl-2 - analysis</subject><subject>Proto-Oncogene Proteins c-bcl-2 - genetics</subject><subject>Time Factors</subject><subject>Transfection</subject><issn>1360-8185</issn><issn>1573-675X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqFkctO3TAQhi1UBJTyCpXForuc-pJxYnYUFVqJmwSV2Fl24pSgnNj1pShvT3I4EhIbZuO5fDPj0Y_QMSUrShj_bk6092lFFiuhkmwlOCvlCvQOOqBQ8UJU8PBp9rkgRU1r2EefY3yacV7zcg_tUwACJRMHaLrL3gcbY-9G7DqsvfPJxT7ifsTehi5vKk0eUg52Ia4mO7i1xtd3BDd2GCK246MeGxs3If4b3HN6xCYnHGybl7weU29cO2Ef3JxJ_f8-TV_QbqeHaI-27yH6c_7z_uxXcXlz8fvs9LJoypKmopNMgKBGAKWyqQl0xkDV0BJ0DcRqrlttjLWyrSnhDVBBwUhbkhZ011WCH6Jvr3Pn5f-yjUmt-7j8VI_W5ahERQgwIj8EqawYFaSeweN34JPLYZyPUBUISaRkbIZOXqEmuBiD7ZQP_VqHSVGiFhnVD3V6e3uv3mRUGxkV6Ln563ZDNmvbvrVudeMvobucRg</recordid><startdate>20041101</startdate><enddate>20041101</enddate><creator>Tey, B T</creator><creator>Al-Rubeai, M</creator><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7QP</scope><scope>7RQ</scope><scope>7TK</scope><scope>7TM</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>U9A</scope><scope>7T5</scope><scope>7X8</scope></search><sort><creationdate>20041101</creationdate><title>Suppression of apoptosis in perfusion culture of Myeloma NS0 cells enhances cell growth but reduces antibody productivity</title><author>Tey, B T ; Al-Rubeai, M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c441t-f926561b65119c805fbb57c145a850ea3adabbee9d8103c51615b9e40d5aff763</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Antibodies, Monoclonal - biosynthesis</topic><topic>Apoptosis</topic><topic>Bacteria</topic><topic>Bioreactors</topic><topic>Cell Count</topic><topic>Cell Culture Techniques</topic><topic>Cell cycle</topic><topic>Cell Proliferation</topic><topic>Cell Survival</topic><topic>Culture Media - analysis</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>Glucose - analysis</topic><topic>Humans</topic><topic>Hybridomas - cytology</topic><topic>Immunoglobulin G - analysis</topic><topic>Microscopy, Confocal</topic><topic>Mortality</topic><topic>Multiple Myeloma - immunology</topic><topic>Multiple Myeloma - pathology</topic><topic>Proteins</topic><topic>Proto-Oncogene Proteins c-bcl-2 - analysis</topic><topic>Proto-Oncogene Proteins c-bcl-2 - genetics</topic><topic>Time Factors</topic><topic>Transfection</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tey, B T</creatorcontrib><creatorcontrib>Al-Rubeai, M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Career & Technical Education Database</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>Immunology Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Apoptosis (London)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tey, B T</au><au>Al-Rubeai, M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Suppression of apoptosis in perfusion culture of Myeloma NS0 cells enhances cell growth but reduces antibody productivity</atitle><jtitle>Apoptosis (London)</jtitle><addtitle>Apoptosis</addtitle><date>2004-11-01</date><risdate>2004</risdate><volume>9</volume><issue>6</issue><spage>843</spage><epage>852</epage><pages>843-852</pages><issn>1360-8185</issn><eissn>1573-675X</eissn><abstract>A spin filter perfusion systems was used to achieve a high cell density culture for two NS0 cell lines in 2 litres bioreactors. One cell line is transfected with the bcl-2 gene (NS0 Bcl-2) encodes the 'anti-apoptotic' human Bcl-2 protein and the other cell line (NS0 Control) with a blank vector. The runs started as batch cultures for two days and were perfused with fresh medium at 0.5 volumes per day (day(-1)) for 4 days, increasing gradually to 2 day(-1) at day 7. The increase of the viable cell density of Bcl-2 cell line was far greater than the control cell line, although they were perfused with the same amount of medium. At the end of the period of each perfusion rate, the viable cell densities of Bcl-2 culture were 30%, 120%, 160% and 220% higher than its control cell line corresponding values. Overall, there was a roughly 9 fold increase in viable cell density from the inoculum for the control culture, but almost a 30 fold increase for the Bcl-2 culture. The mode of cell death in the control culture was initially predominantly by necrosis (viability higher than 80%), but apoptotic cell death became more significant after day 8 of the culture. Cell death in the Bcl-2 culture was almost entirely by necrosis, although it remained at a very low level (less than 5%) to the termination time. The cell cycle distributions for both cell lines were very much similar indicating they have a similar doubling time and G1 to S progression rate. Interestingly, the Bcl-2 cultures exhibited reduced antibody specific production rate with increasing viable cell number and time. The volumetric production rate was, however, similar in both cultures. Bcl-2 as an anti-death protein allowed cells to survive and thus divide to higher cell densities without the need for additional nutrients. Most of the cellular energy in a producer cell line is used for biomass production rather than for antibody production, as was the case with the control cell line.</abstract><cop>Netherlands</cop><pub>Springer Nature B.V</pub><pmid>15505426</pmid><doi>10.1023/b:appt.0000045792.63249.5a</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1360-8185 |
ispartof | Apoptosis (London), 2004-11, Vol.9 (6), p.843-852 |
issn | 1360-8185 1573-675X |
language | eng |
recordid | cdi_proquest_miscellaneous_67005209 |
source | MEDLINE; SpringerLink Journals - AutoHoldings |
subjects | Antibodies, Monoclonal - biosynthesis Apoptosis Bacteria Bioreactors Cell Count Cell Culture Techniques Cell cycle Cell Proliferation Cell Survival Culture Media - analysis Enzyme-Linked Immunosorbent Assay Glucose - analysis Humans Hybridomas - cytology Immunoglobulin G - analysis Microscopy, Confocal Mortality Multiple Myeloma - immunology Multiple Myeloma - pathology Proteins Proto-Oncogene Proteins c-bcl-2 - analysis Proto-Oncogene Proteins c-bcl-2 - genetics Time Factors Transfection |
title | Suppression of apoptosis in perfusion culture of Myeloma NS0 cells enhances cell growth but reduces antibody productivity |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T19%3A07%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Suppression%20of%20apoptosis%20in%20perfusion%20culture%20of%20Myeloma%20NS0%20cells%20enhances%20cell%20growth%20but%20reduces%20antibody%20productivity&rft.jtitle=Apoptosis%20(London)&rft.au=Tey,%20B%20T&rft.date=2004-11-01&rft.volume=9&rft.issue=6&rft.spage=843&rft.epage=852&rft.pages=843-852&rft.issn=1360-8185&rft.eissn=1573-675X&rft_id=info:doi/10.1023/b:appt.0000045792.63249.5a&rft_dat=%3Cproquest_cross%3E2156636791%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=756909922&rft_id=info:pmid/15505426&rfr_iscdi=true |